164 related articles for article (PubMed ID: 22669472)
21. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
22. Quality of life in patients of nasopharyngeal carcinoma: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35.
Chie WC; Hong RL; Lai CC; Ting LL; Hsu MM
Qual Life Res; 2003 Feb; 12(1):93-8. PubMed ID: 12625522
[TBL] [Abstract][Full Text] [Related]
23. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
[TBL] [Abstract][Full Text] [Related]
24. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy.
Fang FM; Liu YT; Tang Y; Wang CJ; Ko SF
Cancer; 2004 Jan; 100(2):425-32. PubMed ID: 14716781
[TBL] [Abstract][Full Text] [Related]
25. High weight loss during radiation treatment changes the prognosis in under-/normal weight nasopharyngeal carcinoma patients for the worse: a retrospective analysis of 2433 cases.
Shen LJ; Chen C; Li BF; Gao J; Xia YF
PLoS One; 2013; 8(7):e68660. PubMed ID: 23869226
[TBL] [Abstract][Full Text] [Related]
26. Relationship Between the Comprehensive Nutritional Index and the EORTC QLQ-H&N35 in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy.
He Y; Chen L; Chen L; Hu W; Wang C; Tang L; Mai H; Li J; Wu L; Fan Y
Nutr Cancer; 2017 Apr; 69(3):436-443. PubMed ID: 28287323
[TBL] [Abstract][Full Text] [Related]
27. Item selection in the development of quality of life scale for nasopharyngeal carcinoma patients.
Gu MF; Du YZ; Chen XL; Li JJ; Zhang HM; Tong Q
Ai Zheng; 2009 Jan; 28(1):82-5. PubMed ID: 19448426
[TBL] [Abstract][Full Text] [Related]
28. Construction of a comprehensive nutritional index and its correlation with quality of life and survival in patients with nasopharyngeal carcinoma undergoing IMRT: A prospective study.
Deng J; He Y; Sun XS; Li JM; Xin MZ; Li WQ; Li ZX; Nie S; Wang C; Li YZ; Chen LP; Chen LM; Zhu SH; Li JW; Hu W; Fan YY; Guo SS; Mai HQ
Oral Oncol; 2019 Nov; 98():62-68. PubMed ID: 31541928
[TBL] [Abstract][Full Text] [Related]
29. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
Yan DF; Zhang WB; Ke SB; Zhao F; Yan SX; Wang QD; Teng LS
BMC Cancer; 2017 Oct; 17(1):678. PubMed ID: 29020937
[TBL] [Abstract][Full Text] [Related]
31. Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma.
Tsai WL; Huang TL; Liao KC; Chuang HC; Lin YT; Lee TF; Huang HY; Fang FM
BMC Cancer; 2014 Nov; 14():856. PubMed ID: 25413127
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
[TBL] [Abstract][Full Text] [Related]
33. Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
Du XJ; Chen L; Li WF; Tang LL; Mao YP; Guo R; Sun Y; Lin AH; Ma J
Head Neck; 2017 Mar; 39(3):492-497. PubMed ID: 27997061
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
Tu X; Ren J; Zhao Y
Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
[TBL] [Abstract][Full Text] [Related]
35. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
[TBL] [Abstract][Full Text] [Related]
36. Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.
Xu BQ; Tu ZW; Tao YL; Liu ZG; Li XH; Yi W; Jiang CB; Xia YF
Chin J Cancer; 2016 Apr; 35():37. PubMed ID: 27056488
[TBL] [Abstract][Full Text] [Related]
37. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
[TBL] [Abstract][Full Text] [Related]
38. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of the tumor volume reduction rate after neoadjuvant chemotherapy in patients with locoregional advanced nasopharyngeal carcinoma.
Yang H; Liu Y; Zhang R; Ye Y; Chen Q; Qin Q; Huang L; Li X; Cai R; Tang H; Jiang W
Oral Oncol; 2020 Nov; 110():104897. PubMed ID: 32679404
[TBL] [Abstract][Full Text] [Related]
40. Pretreatment anemia and survival in nasopharyngeal carcinoma.
Zhang LN; Tang J; Lan XW; OuYang PY; Xie FY
Tumour Biol; 2016 Feb; 37(2):2225-31. PubMed ID: 26358251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]